All HTx consortium partners met for the second time in Bern, Switzerland at the HTx General Assembly 2020 between February 6-7. The program started with an overview of HTx's first year from the project coordinator, Wim Goettsch (University of Utrecht) followed by opening remarks from Georgia Salanti...
The conceptual framework of the HTx case study on Diabetes was presented at the poster section of the International Conference of Advanced Technologies & Treatments for Diabetes in Madrid, held between 19-22 February 2020. The HTx consortium was represented by Gema García Sáez and Maria Elena Hernando from the Universidad Politécnica...
The framework and potentials of HTx were discussed at the ISPOR Europe 2019 conference within the ISPOR IDEAS LAB in Copenhagen, November 2019. HTx was presented by Wim Goettsch, Associate Professor for HTA at Utrecht University (Utrecht, Netherlands). You can find the abstract of the ISPOR...
The concept of the HTx diabetes case study was presented at the Annual Conference of the Biomedical Engineering Spanish Society held between 27-29 November 2019, in Santander, Spain. The HTx Consortium was represented by the Universidad Politécnica de Madrid, (Madrid, Spain). Scroll down for the poster abstract (in...
The concept and aims of the HTx project, highlighting the potentials for collaboration was disseminated extensively for various stakeholders in Bulgaria during 2019. These activities - lead by Guenka Petrova from the Medical University of Sofia - included: June 7, 2019 - HTx concept presented...
The first Expert Forum of HTx was held in Barcelona, on the 25th of November, 2019. The meeting proved to be an excellent platform for sharing with and learning from other H2020 and IMI projects such as IMI Prefer, IMI EHDEN, IMI-GetReal H2020 HTA Impact,...
On the 29th of November 2019, two patient representatives, from Eurordis – Rare Diseases Europe and from EMSP – European Multiple Sclerosis Platform, visited the Institute of Social and Preventive Medicine (ISPM) at the University of Bern, led by Prof Georgia Salanti, responsible for a...
The early results of HTx were presented at the Graduate School for Health Sciences Symposium (November 19 - 20, 2019) in Thun, Switzerland by two PhD students of University of Bern. Poster title: 'A two-stage prediction model for heterogeneous effects for many treatment options' Poster presenter:...
The HTx project was presented in a keynote lecture at the Pharmaceutical Pricing and Reimbursement (PPRI) Conference in Vienna (Austria), on the 24th of October 2019. Title: The need for better HTA methodology for more complex and personalised medicine Presenter: Wim Goettsch, Utrecht University, The Netherlands The presentation...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]A great contribution of HTx’s work was presented at the XXXIst Conference of the Austro-Swiss Region [ ROeS ] of the International Biometric Society in Lausanne, Switzerland, September 9-12, 2019. The title of the presentation was ’ A two-stage...